var vertoff1;////master offset////
var ar = new Array(); 
var cxx = new Array();
var ked = new Array();
var pxa = new Array();
var pya = new Array();
var zss = new Array();
var ckn = new Array();
var ckar = new Array();
var kedx = new Array();
var acx = new Array();
var thn = new Array();
var ctl = new Array();
var tot;
var ty;
var co;
var i,ii,p2,p3,px,py,pf; 
var txx;
var pxx,pyy;
var pxxx,pyyy;
var sc;
var f,fl;
if(vertoff1==null) vertoff1=0;
var vertoff2=(1*vertoff1)+90;
var cbx=10;
var cby=(1*vertoff1)+10;
var zs=1;
var tcu=0;
var c = new RegExp('px','g');
var oz,ozn;
var tax=1010;
var tay=505;
var taxtar=1010;
var taytar=505;
var scX,scY;
var ms=0;
var allo =0;
var kv=50;
var ckount =0;
var hko=0;
var iz=0;
var kx=0;
var max=0;
var IE=1;
var hili=null;
var zts=16;
var rdo=null;
var svv=0;

zss[1]=8;
zss[2]=4;
zss[4]=2;
IE = (document.all) ? 1 : 0;
//
function spacer()
{
 for(i=0;i<16;i++){acx[ i ] =0;}
for(i=0;i<tot;i++)
{
cxx[i]=0;
p2 = ar[i].split(",")[1];  
if(allo==1) {eval( "document.cbox."+p2+".checked=true");}else
if(rdo!=p2) eval( "document.cbox."+p2+".checked=false");
ked[i]=eval( "document.cbox."+p2+".checked");
kx=kedx[i];
acx[ kx ] += 1;
kx=acx[ kx ] ;
if( kx < kv) thn[i]=1;
else thn[i]=0;
}
for(i=0;i<tot;i++)
{
if( ked[i] )
{
if(thn[i]==1 )
{
sc=1;
{
for(ii=0;ii<tot;ii++)
{
if(ii != i)
{
if( ked[ii])
{
pxx =cxx[ii]+pxa[ii];
pyy =pya[ii];
pxxx=pxx-(cxx[i]+pxa[i]);
pyyy=pyy-pya[i];
if(pxxx<0) pxxx=pxxx*-1;
if(pyyy<0) pyyy=pyyy*-1;
if( pxxx <1)
{
if(pyyy <1)
{ 
if(thn[ii]==1 ){cxx[ii]=cxx[ii]-(sc*zss[zs] );sc += 1;}
}
}
}
}
}
}
}
}
}
}
//////
function cposit(ckna)
{
ckn[ckount]=ckna;
ckount +=1;
cby=cby+22;
if (cby >(59+vertoff1) )
{
cby=vertoff1+10;
cbx=cbx+200;
}
}
//////
function repo()
{
var tj=456;
if(ckount>6) tj=300;
if(ckount>9) tj=230;
if(ckount>12) tj=184;
if(ckount>15) tj=156;
hko=ckount;
ckount -= 1;
tmp1=vertoff1+10;
tmp=50;
document.all.item("spa").style.top =  vertoff1;
//document.all.item("slid").style.top =  vertoff1+1;
//document.all.item("knob").style.top =  vertoff1+19;
while(ckount >= 0 )
{
document.all.item(ckn[ckount]).style.left =tmp;
document.all.item(ckn[ckount]).style.top =  tmp1;
tmp1=tmp1+22;
if(tmp1>(vertoff1+59))
{
tmp1=vertoff1+10;
tmp=tmp+tj;
}
ckount -= 1;
}
}
///
function tmo(evt,name,zoo,texx,sum){
tmp=(document.all.item(name).style.left);
f = "";  
tmp= (tmp.replace(c,f));
tmp=1*tmp;
tmp=tmp+40;
if(tmp>600) tmp=500;
document.all.item(texx).style.left =tmp;
tmp1= (document.all.item(name).style.top) ;
f = ""; 	 
tmp1= (tmp1.replace(c,f)); 
tmp1=1*tmp1;
if(tmp==500) tmp1=tmp1+40;
document.all.item(texx).style.top =  tmp1;
zts=16;
hili=zoo;
oz=document.all.item(name).style.zIndex;
document.all.item(name).style.zIndex=678;
ozn=name;
}
//
function tmo1(texx,zoo,sum)
{
hili=null;
document.all[texx].style.top = -100000;
document.all.item(zoo).width = 16;
document.all.item(zoo).height = 16;
document.all.item(ozn).style.zIndex=oz;
}
//
function cax()
{
for(i=0;i<tot;i++)
{
co = ctl[i];
if( ked[i] )
{
if( thn[i]==1)
{
px=pxa[i];
py=pya[i];
txx=cxx[i];
px=txx+(1*px);
py=(1*py);
if(py<0){py=180-(py*-1);}else{py=(py)+180}
if(px>=0){px=90-px;}else{px=(px*-1)+90}
px=(px*2.8)*(zs);
py=(py*2.8)*(zs);
if(zs!=1)	{px= px +scY;py= py + scX;}
document.all.item(co).style.top = px;
document.all.item(co).style.left = py;
}
else
{document.all.item(co).style.top = -100000;}
}
else
{document.all.item(co).style.top = -100000;}
}
}

function caz(noc)
{
allo=0;
rdo=noc;
ca();
}
//
function ca()
{
spacer();
cax();
}
function alloff()
{
allo=1;
ca();
//allo=0;
document.cbox.b1.checked=false;
}
function pview(gi)
{
var nX,nY;
	switch(gi)
	{
	case 0:
	  taxtar =1010; taytar =505;
	  nX=0;nY=0;
	  scX=nX;  scY=nY;
	  zs=1;
	  break;

	case 1:
	  taxtar =4040; taytar =2020;
	  nX=-440;nY=-380;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	case 2:
	  taxtar =4040; taytar =2020;
	  nX=-1780;nY=-200;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	case 3:
	  taxtar =4040; taytar =2020;
	  nX=-2710;nY=-440;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	case 4:
	  taxtar =4040; taytar =2020;
	  nX=-2910;nY=-740;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	case 5:
	  taxtar =4040; taytar =2020;
	  nX=-3030;nY=-1050;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	case 6:
	  taxtar =2020; taytar =1010;
	  nX=-210;nY=-360;
	  scX=nX;  scY=nY;
	  zs=2;
	  break;

	case 7:
	  taxtar =2020; taytar =1010;
	  nX=-810;nY=-240;
	  scX=nX;  scY=nY;
	  zs=2;
	  break;

	case 8:
	  taxtar =4040; taytar =2020;
	  nX=-1980;nY=-460;
	  scX=nX;  scY=nY;
	  zs=4;
	  break;

	}
	document.all.item("ear").width =taxtar;
	document.all.item("ear").height = taytar;
	document.all.item("bkgd").style.left = nX;
	document.all.item("bkgd").style.top =nY;

ca();
}
//
function slider(evt){
if (IE) newY=(evt.y);
else newY=(evt.pageY);
if(IE)newY=newY+document.body.scrollTop;
	if(newY>(vertoff1+72)) newY=(vertoff1+72);
	if(newY<(vertoff1+22)) newY=(vertoff1+22);
	kv=3+(50-(newY-(vertoff1+12))) / max;
	document.all.item("knob").style.top =newY-6;
}
/////
function zoom(evt){
if (IE) newY=(evt.y);
else newY=(evt.pageY);
if (IE) newY=newY+document.body.scrollTop;
if (IE) newX=(evt.x);
else newX=(evt.pageX);
newX=(-(newX));
newY=-(newY-vertoff2);

zs = zs *2;
if(zs>4) zs=1;
if(zs==4)
{
taxtar =4040;
taytar =2020;
document.all.item("ear").width =taxtar;
document.all.item("ear").height = taytar;
newX=(scX*2)+newX;
newY=(scY*2)+newY;
if(newX<-3030) newX=-3030;
if(newX>0) newX=0;
if(newY<-1515) newY=-1515;
if(newY>0) newY=0;
document.all.item("bkgd").style.left = newX;
document.all.item("bkgd").style.top =newY;
 scX=newX;
 scY=newY;
}
if(zs==2)
{
taxtar =2020;
taytar =1010;
document.all.item("ear").width =taxtar;
document.all.item("ear").height = taytar;
if(newX<-1010) newX=-1010;
if(newX>0) newX=0;
if(newY<-505) newY=-505;
if(newY>0) newY=0;
document.all.item("bkgd").style.left = newX;
document.all.item("bkgd").style.top =newY;
 scX=newX;
 scY=newY;
}
if(zs==1)
{
taxtar =1010;
taytar =505;
document.all.item("bkgd").style.left = 0;
document.all.item("bkgd").style.top = 0;
scX=0;
scY=0;
document.all.item("ear").width =taxtar;
document.all.item("ear").height = taytar;
}
ca();
}
function prespacer()
{
tcu=0;
for(i=0;i<tot;i++)
{
cxx[i]=0;
co = ar[i].split(",")[0]; 
p2 = ar[i].split(",")[1];  
px = ar[i].split(",")[2];  
py = ar[i].split(",")[3]; 
ctl[i]=co;	  
px=(1*px);
py=(1*py);
pxa[i] =(1* px);
pya[i] =(1* py);
if((px==0)&&(py==0))
{

if (tcu<14)
{
py=-179;  px= 79; 
pxa[i] =(1* px);
pya[i] =(1* py);
ar[i]=co+","+p2+","+px+","+py;
}
else  if (tcu<28)
{
py=-168;  px= 79; 
pxa[i] =(1* px);
pya[i] =(1* py);
ar[i]=co+","+p2+","+px+","+py;
}
else  if (tcu<42)
{
py=-157;  px= 79; 
pxa[i] =(1* px);
pya[i] =(1* py);
ar[i]=co+","+p2+","+px+","+py;
}
else  if (tcu<56)
{
py=-146;  px= 79; 
pxa[i] =(1* px);
pya[i] =(1* py);
ar[i]=co+","+p2+","+px+","+py;
}
else  if (tcu<70)
{
py=-135;  px= 79; 
pxa[i] =(1* px);
pya[i] =(1* py);
ar[i]=co+","+p2+","+px+","+py;
}
tcu=tcu+1;
}
}
///
for(i=0;i<tot;i++)
{
ckar[i]=0;
}
iz=0;
for(i=0;i<tot;i++)
{
var itx;
p2 = ar[i].split(",")[1];  
itx=0;
for(ii=0;ii<16;ii++)
{
if(ckar[ii]==p2) itx=1;
}
if( itx==0)
{
ckar[iz]=p2; iz= iz+1;
}
}
for(i=0;i<tot;i++)
{
p2 = ar[i].split(",")[1];  
for(ii=0;ii<iz;ii++)
{
if(ckar[ii]==p2) kedx[i]=ii;
}
}
for(i=0;i<16;i++)
{
acx[ i ] =0;
}
for(i=0;i<tot;i++)
{
kx=kedx[i];
acx[ kx ] += 1;
}
max=1;
for(i=0;i<16;i++)
{
if(acx[ i ] > max) max=acx[i];
}
//max=50/max;
}
//
function zoomto()
{
if(hili != null)
{
document.all.item(hili).width = zts;
document.all.item(hili).height = zts; 
zts=zts+2;
if(zts>32) zts=32;
}
}
//
function moremax() {
kv=max+1;
document.cbox2.b22.checked=false;
ca();
}
//
function less() {
kv=kv-2;
if(kv<2) kv=2;
document.cbox2.b21.checked=false;
ca();
}
//
function more() {
kv=kv+2;
if(kv>max+1) kv=max+1;
document.cbox2.b20.checked=false;
ca();
}
//
function resizeImage(evt,name){
if (IE) newY=(evt.y);
else newY=(evt.pageY);
if (IE) newY=newY+document.body.scrollTop;
if (IE) newX=(evt.x);
else newX=(evt.pageX);
newY=(newY-vertoff2);
if(zs==1)
{
document.all.item("bkgd").style.left = 0;
document.all.item("bkgd").style.top = 0;
 scX=0;
 scY=0;
}
if(zs==2)
{
newX = ((newX)-505)*-1;
newY = (newY-255)*-1;
newX=scX+newX;
newY=scY+newY;
if(newX<-1010) newX=-1010;
if(newX>0) newX=0;
if(newY<-505) newY=-505;
if(newY>0) newY=0;
document.all.item("bkgd").style.left =newX;
document.all.item("bkgd").style.top = newY;
scX=newX;
scY=newY;
}
if(zs==4)
{
newX = ((newX)-505)*-1;
newY = (newY-255)*-1;
newX=scX+newX;
newY=scY+newY;
if(newX<-3030) newX=-3030;
if(newX>0) newX=0;
if(newY<-1515) newY=-1515;
if(newY>0) newY=0;
document.all.item("bkgd").style.left =newX;
document.all.item("bkgd").style.top = newY;
scX=newX;
scY=newY;
}
cax();
}

var mi=window.setInterval("zoomto()",20);

document.write("<FONT FACE=\"Arial, sans-serif\">")
document.write("<font size=4 color =#ffffee>")
ai=0;
document.write("<FORM name=\"cbox\">");
document.write("<font size=3 color =#ffffcc>")

document.write("<img src=\"geo_news/space1.gif\" style=\"position:absolute;left:0;top:0;\" id=\"spa\"  width=\"1010\" height=\"97\" > ");
document.write("<div id=\"b1\" style=\"position:absolute;left:3;top:4;\"><INPUT TYPE=CHECKBOX  NAME=\"b1\"  ONCLICK=\"alloff()\">All</div>");
document.write("</font><font size=4 color =#ffffcc>")
document.write("<img src=\"slide.gif\"   style=\"position:absolute;left:3;top:-19000;\" id=\"slid\" width=\"44\" height=\"90\" >");
document.write("<a   ONMOUSEOUT=\"ca();\" ONMOUSEMOVE=\"slider(event)\"><img style=\"position:absolute;left:18;top:-19000;\"  id=\"knob\" src=\"knob.gif\"   width=\"13\" height=\"13\" ></a>");
document.write("<div id=\"ch_asap_biopharmaBfck0\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck0\"  ONCLICK=\"caz('ch_asap_biopharmaBck0')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=biotechnology buyout&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=AP&location=&fl=0&n=10\" TARGET=\"_blank\">Biotech Buyout - AP Newswire </a><img src=\"/images/geo_news/icons/_agreement_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck0');
document.write("<div id=\"ch_asap_biopharmaBfck1\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck1\"  ONCLICK=\"caz('ch_asap_biopharmaBck1')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=biotech collaboration&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=Business+Wire&location=&fl=0&n=20\" TARGET=\"_blank\">Biotech Collab - BusinessWire </a><img src=\"/images/geo_news/icons/_conversation_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck1');
document.write("<div id=\"ch_asap_biopharmaBfck2\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck2\"  ONCLICK=\"caz('ch_asap_biopharmaBck2')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=biotech collaboration&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=PR+Newswire&location=&fl=0&n=10\" TARGET=\"_blank\">Biotech Collab - PR Newswire </a><img src=\"/images/geo_news/icons/_competition_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck2');
document.write("<div id=\"ch_asap_biopharmaBfck3\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck3\"  ONCLICK=\"caz('ch_asap_biopharmaBck3')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=biotechnology partner&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=PR+Newswire&location=&fl=0&n=20\" TARGET=\"_blank\">Biotech Partnering - PR Newswire </a><img src=\"/images/geo_news/icons/_business_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck3');
document.write("<div id=\"ch_asap_biopharmaBfck5\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck5\"  ONCLICK=\"caz('ch_asap_biopharmaBck5')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=pharma collaboration&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=Business+Wire&location=&fl=0&n=20\" TARGET=\"_blank\">Pharma Collab - Business Wire </a><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck5');
document.write("<div id=\"ch_asap_biopharmaBfck6\" style=\"position:absolute;left:",cbx,";top:",cby,";\"><INPUT TYPE=RADIO checked=\"checked\" NAME=\"ch_asap_biopharmaBck6\"  ONCLICK=\"caz('ch_asap_biopharmaBck6')\"> <a href=\"http://news.search.yahoo.com/search/news?ei=UTF-8&fr=&va=pharma collaboration&va_vt=any&vp=&vp_vt=any&vo=&vo_vt=any&ve=&ve_vt=any&datesort=&pub=1&timeago=&smonth=&sday=7&emonth=12&eday=10&source=PR+Newswire&location=&fl=0&n=10\" TARGET=\"_blank\">Pharma Collab - PR NewsWire </a><img src=\"/images/geo_news/icons/_science_32.bmp\" width=\"16\" height=\"16\"></div>");cposit('ch_asap_biopharmaBfck6');

document.write("</FORM>");repo();
document.write("</div><div  style=\"position:absolute;left:0;top:"+vertoff2+";clip:rect(0px 1010px 505px 0px);width:1010;height:505\">");
document.write("<a ONDBLCLICK=\"zoom(event)\" ONCLICK=\"resizeImage(event,'ear') \"><img id=\"bkgd\" style=\"position:absolute;left:0;top:0;\" src=\"http://www.energyvoyager.com/images/geo_news/maps/earth64.jpg\" name=\"ear\" width=\"1010\" height=\"505\"   ></a>"); 
document.write("<div id=\"ch_asap_biopharmaB0\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/ap/081124/eli_lilly_imclone.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_agreement_32.bmp\" name=\"ch_asap_biopharmaBi0\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB0','ch_asap_biopharmaBi0','ch_asap_biopharmaBt0','ch_asap_biopharmaBs0')\" onmouseout=\"tmo1('ch_asap_biopharmaBt0','ch_asap_biopharmaBi0','ch_asap_biopharmaBs0')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB0,ch_asap_biopharmaBck0,39.750000,-86.166702"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB1\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/ap/081125/roche_memory_pharmaceuticals_acquisition.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_agreement_32.bmp\" name=\"ch_asap_biopharmaBi1\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB1','ch_asap_biopharmaBi1','ch_asap_biopharmaBt1','ch_asap_biopharmaBs1')\" onmouseout=\"tmo1('ch_asap_biopharmaBt1','ch_asap_biopharmaBi1','ch_asap_biopharmaBs1')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB1,ch_asap_biopharmaBck0,41.048996,-74.040520"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB2\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005649.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi2\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB2','ch_asap_biopharmaBi2','ch_asap_biopharmaBt2','ch_asap_biopharmaBs2')\" onmouseout=\"tmo1('ch_asap_biopharmaBt2','ch_asap_biopharmaBi2','ch_asap_biopharmaBs2')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB2,ch_asap_biopharmaBck1,59.333302,18.083300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB3\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081210/20081210006160.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi3\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB3','ch_asap_biopharmaBi3','ch_asap_biopharmaBt3','ch_asap_biopharmaBs3')\" onmouseout=\"tmo1('ch_asap_biopharmaBt3','ch_asap_biopharmaBi3','ch_asap_biopharmaBs3')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB3,ch_asap_biopharmaBck1,41.110081,-73.421906"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB4\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005839.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi4\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB4','ch_asap_biopharmaBi4','ch_asap_biopharmaBt4','ch_asap_biopharmaBs4')\" onmouseout=\"tmo1('ch_asap_biopharmaBt4','ch_asap_biopharmaBi4','ch_asap_biopharmaBs4')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB4,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB5\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005374.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi5\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB5','ch_asap_biopharmaBi5','ch_asap_biopharmaBt5','ch_asap_biopharmaBs5')\" onmouseout=\"tmo1('ch_asap_biopharmaBt5','ch_asap_biopharmaBi5','ch_asap_biopharmaBs5')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB5,ch_asap_biopharmaBck1,44.966702,-93.333298"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB6\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005818.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi6\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB6','ch_asap_biopharmaBi6','ch_asap_biopharmaBt6','ch_asap_biopharmaBs6')\" onmouseout=\"tmo1('ch_asap_biopharmaBt6','ch_asap_biopharmaBi6','ch_asap_biopharmaBs6')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB6,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB7\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081208/20081208005718.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi7\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB7','ch_asap_biopharmaBi7','ch_asap_biopharmaBt7','ch_asap_biopharmaBs7')\" onmouseout=\"tmo1('ch_asap_biopharmaBt7','ch_asap_biopharmaBi7','ch_asap_biopharmaBs7')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB7,ch_asap_biopharmaBck1,41.110081,-73.421906"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB8\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081202/20081202005813.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi8\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB8','ch_asap_biopharmaBi8','ch_asap_biopharmaBt8','ch_asap_biopharmaBs8')\" onmouseout=\"tmo1('ch_asap_biopharmaBt8','ch_asap_biopharmaBi8','ch_asap_biopharmaBs8')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB8,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB9\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081201/20081201006194.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi9\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB9','ch_asap_biopharmaBi9','ch_asap_biopharmaBt9','ch_asap_biopharmaBs9')\" onmouseout=\"tmo1('ch_asap_biopharmaBt9','ch_asap_biopharmaBi9','ch_asap_biopharmaBs9')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB9,ch_asap_biopharmaBck1,-33.916698,151.166700"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB10\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081126/20081126005212.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi10\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB10','ch_asap_biopharmaBi10','ch_asap_biopharmaBt10','ch_asap_biopharmaBs10')\" onmouseout=\"tmo1('ch_asap_biopharmaBt10','ch_asap_biopharmaBi10','ch_asap_biopharmaBs10')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB10,ch_asap_biopharmaBck1,32.083302,34.766701"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB11\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081124/20081124005619.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi11\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB11','ch_asap_biopharmaBi11','ch_asap_biopharmaBt11','ch_asap_biopharmaBs11')\" onmouseout=\"tmo1('ch_asap_biopharmaBt11','ch_asap_biopharmaBi11','ch_asap_biopharmaBs11')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB11,ch_asap_biopharmaBck1,40.138557,-75.191422"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB12\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081119/20081119005993.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi12\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB12','ch_asap_biopharmaBi12','ch_asap_biopharmaBt12','ch_asap_biopharmaBs12')\" onmouseout=\"tmo1('ch_asap_biopharmaBt12','ch_asap_biopharmaBi12','ch_asap_biopharmaBs12')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB12,ch_asap_biopharmaBck1,50.716702,12.050000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB13\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081120/20081120005584.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi13\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB13','ch_asap_biopharmaBi13','ch_asap_biopharmaBt13','ch_asap_biopharmaBs13')\" onmouseout=\"tmo1('ch_asap_biopharmaBt13','ch_asap_biopharmaBi13','ch_asap_biopharmaBs13')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB13,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB14\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081120/20081120005503.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi14\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB14','ch_asap_biopharmaBi14','ch_asap_biopharmaBt14','ch_asap_biopharmaBs14')\" onmouseout=\"tmo1('ch_asap_biopharmaBt14','ch_asap_biopharmaBi14','ch_asap_biopharmaBs14')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB14,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB15\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081120/20081120005526.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi15\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB15','ch_asap_biopharmaBi15','ch_asap_biopharmaBt15','ch_asap_biopharmaBs15')\" onmouseout=\"tmo1('ch_asap_biopharmaBt15','ch_asap_biopharmaBi15','ch_asap_biopharmaBs15')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB15,ch_asap_biopharmaBck1,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB16\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081119/20081119005891.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi16\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB16','ch_asap_biopharmaBi16','ch_asap_biopharmaBt16','ch_asap_biopharmaBs16')\" onmouseout=\"tmo1('ch_asap_biopharmaBt16','ch_asap_biopharmaBi16','ch_asap_biopharmaBs16')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB16,ch_asap_biopharmaBck1,35.825523,-78.316673"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB17\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081118/20081118006817.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi17\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB17','ch_asap_biopharmaBi17','ch_asap_biopharmaBt17','ch_asap_biopharmaBs17')\" onmouseout=\"tmo1('ch_asap_biopharmaBt17','ch_asap_biopharmaBi17','ch_asap_biopharmaBs17')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB17,ch_asap_biopharmaBck1,47.583302,-122.333300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB18\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081118/20081118005285.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi18\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB18','ch_asap_biopharmaBi18','ch_asap_biopharmaBt18','ch_asap_biopharmaBs18')\" onmouseout=\"tmo1('ch_asap_biopharmaBt18','ch_asap_biopharmaBi18','ch_asap_biopharmaBs18')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB18,ch_asap_biopharmaBck1,39.750000,-105.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB19\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081113/20081113005017.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_conversation_32.bmp\" name=\"ch_asap_biopharmaBi19\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB19','ch_asap_biopharmaBi19','ch_asap_biopharmaBt19','ch_asap_biopharmaBs19')\" onmouseout=\"tmo1('ch_asap_biopharmaBt19','ch_asap_biopharmaBi19','ch_asap_biopharmaBs19')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB19,ch_asap_biopharmaBck1,42.279205,-85.583900"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB20\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/new036.html?.v=71\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi20\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB20','ch_asap_biopharmaBi20','ch_asap_biopharmaBt20','ch_asap_biopharmaBs20')\" onmouseout=\"tmo1('ch_asap_biopharmaBt20','ch_asap_biopharmaBi20','ch_asap_biopharmaBs20')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB20,ch_asap_biopharmaBck2,38.863441,-104.791916"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB21\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081204/lath061.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi21\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB21','ch_asap_biopharmaBi21','ch_asap_biopharmaBt21','ch_asap_biopharmaBs21')\" onmouseout=\"tmo1('ch_asap_biopharmaBt21','ch_asap_biopharmaBi21','ch_asap_biopharmaBs21')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB21,ch_asap_biopharmaBck2,41.260483,-96.012993"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB22\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/aqw551.html?.v=13\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi22\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB22','ch_asap_biopharmaBi22','ch_asap_biopharmaBt22','ch_asap_biopharmaBs22')\" onmouseout=\"tmo1('ch_asap_biopharmaBt22','ch_asap_biopharmaBi22','ch_asap_biopharmaBs22')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB22,ch_asap_biopharmaBck2,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB23\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/clw070.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi23\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB23','ch_asap_biopharmaBi23','ch_asap_biopharmaBt23','ch_asap_biopharmaBs23')\" onmouseout=\"tmo1('ch_asap_biopharmaBt23','ch_asap_biopharmaBi23','ch_asap_biopharmaBs23')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB23,ch_asap_biopharmaBck2,35.207191,-80.829224"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB24\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/ukm013.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi24\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB24','ch_asap_biopharmaBi24','ch_asap_biopharmaBt24','ch_asap_biopharmaBs24')\" onmouseout=\"tmo1('ch_asap_biopharmaBt24','ch_asap_biopharmaBi24','ch_asap_biopharmaBs24')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB24,ch_asap_biopharmaBck2,59.599998,16.583300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB25\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/3796546en_public.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_competition_32.bmp\" name=\"ch_asap_biopharmaBi25\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB25','ch_asap_biopharmaBi25','ch_asap_biopharmaBt25','ch_asap_biopharmaBs25')\" onmouseout=\"tmo1('ch_asap_biopharmaBt25','ch_asap_biopharmaBi25','ch_asap_biopharmaBs25')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB25,ch_asap_biopharmaBck2,47.383301,8.550000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB26\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081209/netu084.html?.v=77\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi26\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB26','ch_asap_biopharmaBi26','ch_asap_biopharmaBt26','ch_asap_biopharmaBs26')\" onmouseout=\"tmo1('ch_asap_biopharmaBt26','ch_asap_biopharmaBi26','ch_asap_biopharmaBs26')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB26,ch_asap_biopharmaBck3,44.198433,-72.501411"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB27\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081204/lath061.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi27\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB27','ch_asap_biopharmaBi27','ch_asap_biopharmaBt27','ch_asap_biopharmaBs27')\" onmouseout=\"tmo1('ch_asap_biopharmaBt27','ch_asap_biopharmaBi27','ch_asap_biopharmaBs27')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB27,ch_asap_biopharmaBck3,41.260483,-96.012993"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB28\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081204/la49750.html?.v=2\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi28\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB28','ch_asap_biopharmaBi28','ch_asap_biopharmaBt28','ch_asap_biopharmaBs28')\" onmouseout=\"tmo1('ch_asap_biopharmaBt28','ch_asap_biopharmaBi28','ch_asap_biopharmaBs28')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB28,ch_asap_biopharmaBck3,32.833302,-117.166700"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB29\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081204/ph49896.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi29\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB29','ch_asap_biopharmaBi29','ch_asap_biopharmaBt29','ch_asap_biopharmaBs29')\" onmouseout=\"tmo1('ch_asap_biopharmaBt29','ch_asap_biopharmaBi29','ch_asap_biopharmaBs29')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB29,ch_asap_biopharmaBck3,47.383301,8.550000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB30\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/aqw551.html?.v=13\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi30\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB30','ch_asap_biopharmaBi30','ch_asap_biopharmaBt30','ch_asap_biopharmaBs30')\" onmouseout=\"tmo1('ch_asap_biopharmaBt30','ch_asap_biopharmaBi30','ch_asap_biopharmaBs30')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB30,ch_asap_biopharmaBck3,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB31\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/aqw512.html?.v=32\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi31\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB31','ch_asap_biopharmaBi31','ch_asap_biopharmaBt31','ch_asap_biopharmaBs31')\" onmouseout=\"tmo1('ch_asap_biopharmaBt31','ch_asap_biopharmaBi31','ch_asap_biopharmaBs31')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB31,ch_asap_biopharmaBck3,38.616699,-90.199997"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB32\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/ukm013.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi32\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB32','ch_asap_biopharmaBi32','ch_asap_biopharmaBt32','ch_asap_biopharmaBs32')\" onmouseout=\"tmo1('ch_asap_biopharmaBt32','ch_asap_biopharmaBi32','ch_asap_biopharmaBs32')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB32,ch_asap_biopharmaBck3,59.599998,16.583300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB33\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/3796546en_public.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi33\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB33','ch_asap_biopharmaBi33','ch_asap_biopharmaBt33','ch_asap_biopharmaBs33')\" onmouseout=\"tmo1('ch_asap_biopharmaBt33','ch_asap_biopharmaBi33','ch_asap_biopharmaBs33')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB33,ch_asap_biopharmaBck3,47.383301,8.550000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB34\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081203/nyw078.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi34\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB34','ch_asap_biopharmaBi34','ch_asap_biopharmaBt34','ch_asap_biopharmaBs34')\" onmouseout=\"tmo1('ch_asap_biopharmaBt34','ch_asap_biopharmaBi34','ch_asap_biopharmaBs34')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB34,ch_asap_biopharmaBck3,53.333000,-6.250000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB35\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081202/aqtu024.html?.v=74\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi35\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB35','ch_asap_biopharmaBi35','ch_asap_biopharmaBt35','ch_asap_biopharmaBs35')\" onmouseout=\"tmo1('ch_asap_biopharmaBt35','ch_asap_biopharmaBi35','ch_asap_biopharmaBs35')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB35,ch_asap_biopharmaBck3,37.429291,-122.138161"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB36\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081201/la48968.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi36\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB36','ch_asap_biopharmaBi36','ch_asap_biopharmaBt36','ch_asap_biopharmaBs36')\" onmouseout=\"tmo1('ch_asap_biopharmaBt36','ch_asap_biopharmaBi36','ch_asap_biopharmaBs36')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB36,ch_asap_biopharmaBck3,32.833302,-117.166700"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB37\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081125/netu042.html?.v=74\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi37\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB37','ch_asap_biopharmaBi37','ch_asap_biopharmaBt37','ch_asap_biopharmaBs37')\" onmouseout=\"tmo1('ch_asap_biopharmaBt37','ch_asap_biopharmaBi37','ch_asap_biopharmaBs37')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB37,ch_asap_biopharmaBck3,40.915741,-77.680466"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB38\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081121/clf056.html?.v=101\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi38\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB38','ch_asap_biopharmaBi38','ch_asap_biopharmaBt38','ch_asap_biopharmaBs38')\" onmouseout=\"tmo1('ch_asap_biopharmaBt38','ch_asap_biopharmaBi38','ch_asap_biopharmaBs38')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB38,ch_asap_biopharmaBck3,42.274487,-83.739258"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB39\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081119/aqw051.html?.v=79\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi39\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB39','ch_asap_biopharmaBi39','ch_asap_biopharmaBt39','ch_asap_biopharmaBs39')\" onmouseout=\"tmo1('ch_asap_biopharmaBt39','ch_asap_biopharmaBi39','ch_asap_biopharmaBs39')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB39,ch_asap_biopharmaBck3,37.643631,-122.076973"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB40\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081117/ny46728.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_business_32.bmp\" name=\"ch_asap_biopharmaBi40\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB40','ch_asap_biopharmaBi40','ch_asap_biopharmaBt40','ch_asap_biopharmaBs40')\" onmouseout=\"tmo1('ch_asap_biopharmaBt40','ch_asap_biopharmaBi40','ch_asap_biopharmaBs40')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB40,ch_asap_biopharmaBck3,40.928585,-73.784233"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB41\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081210/20081210005216.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi41\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB41','ch_asap_biopharmaBi41','ch_asap_biopharmaBt41','ch_asap_biopharmaBs41')\" onmouseout=\"tmo1('ch_asap_biopharmaBt41','ch_asap_biopharmaBi41','ch_asap_biopharmaBs41')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB41,ch_asap_biopharmaBck5,47.771671,-122.204422"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB42\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005815.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi42\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB42','ch_asap_biopharmaBi42','ch_asap_biopharmaBt42','ch_asap_biopharmaBs42')\" onmouseout=\"tmo1('ch_asap_biopharmaBt42','ch_asap_biopharmaBi42','ch_asap_biopharmaBs42')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB42,ch_asap_biopharmaBck5,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB43\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005736.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi43\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB43','ch_asap_biopharmaBi43','ch_asap_biopharmaBt43','ch_asap_biopharmaBs43')\" onmouseout=\"tmo1('ch_asap_biopharmaBt43','ch_asap_biopharmaBi43','ch_asap_biopharmaBs43')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB43,ch_asap_biopharmaBck5,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB44\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005818.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi44\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB44','ch_asap_biopharmaBi44','ch_asap_biopharmaBt44','ch_asap_biopharmaBs44')\" onmouseout=\"tmo1('ch_asap_biopharmaBt44','ch_asap_biopharmaBi44','ch_asap_biopharmaBs44')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB44,ch_asap_biopharmaBck5,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB45\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081209/20081209005374.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi45\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB45','ch_asap_biopharmaBi45','ch_asap_biopharmaBt45','ch_asap_biopharmaBs45')\" onmouseout=\"tmo1('ch_asap_biopharmaBt45','ch_asap_biopharmaBi45','ch_asap_biopharmaBs45')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB45,ch_asap_biopharmaBck5,44.966702,-93.333298"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB46\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081203/20081203005218.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi46\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB46','ch_asap_biopharmaBi46','ch_asap_biopharmaBt46','ch_asap_biopharmaBs46')\" onmouseout=\"tmo1('ch_asap_biopharmaBt46','ch_asap_biopharmaBi46','ch_asap_biopharmaBs46')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB46,ch_asap_biopharmaBck5,42.373745,-71.110558"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB47\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081206/20081206005012.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi47\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB47','ch_asap_biopharmaBi47','ch_asap_biopharmaBt47','ch_asap_biopharmaBs47')\" onmouseout=\"tmo1('ch_asap_biopharmaBt47','ch_asap_biopharmaBi47','ch_asap_biopharmaBs47')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB47,ch_asap_biopharmaBck5,47.583302,-122.333300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB48\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081206/20081206005011.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi48\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB48','ch_asap_biopharmaBi48','ch_asap_biopharmaBt48','ch_asap_biopharmaBs48')\" onmouseout=\"tmo1('ch_asap_biopharmaBt48','ch_asap_biopharmaBi48','ch_asap_biopharmaBs48')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB48,ch_asap_biopharmaBck5,47.583302,-122.333300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB49\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081204/20081204005474.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi49\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB49','ch_asap_biopharmaBi49','ch_asap_biopharmaBt49','ch_asap_biopharmaBs49')\" onmouseout=\"tmo1('ch_asap_biopharmaBt49','ch_asap_biopharmaBi49','ch_asap_biopharmaBs49')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB49,ch_asap_biopharmaBck5,40.750000,-74.000000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB50\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081201/20081201005218.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi50\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB50','ch_asap_biopharmaBi50','ch_asap_biopharmaBt50','ch_asap_biopharmaBs50')\" onmouseout=\"tmo1('ch_asap_biopharmaBt50','ch_asap_biopharmaBi50','ch_asap_biopharmaBs50')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB50,ch_asap_biopharmaBck5,47.771671,-122.204422"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB51\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081127/20081127005021.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi51\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB51','ch_asap_biopharmaBi51','ch_asap_biopharmaBt51','ch_asap_biopharmaBs51')\" onmouseout=\"tmo1('ch_asap_biopharmaBt51','ch_asap_biopharmaBi51','ch_asap_biopharmaBs51')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB51,ch_asap_biopharmaBck5,55.400002,10.416700"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB52\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081126/20081126005212.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi52\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB52','ch_asap_biopharmaBi52','ch_asap_biopharmaBt52','ch_asap_biopharmaBs52')\" onmouseout=\"tmo1('ch_asap_biopharmaBt52','ch_asap_biopharmaBi52','ch_asap_biopharmaBs52')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB52,ch_asap_biopharmaBck5,32.083302,34.766701"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB53\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081120/20081120005519.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi53\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB53','ch_asap_biopharmaBi53','ch_asap_biopharmaBt53','ch_asap_biopharmaBs53')\" onmouseout=\"tmo1('ch_asap_biopharmaBt53','ch_asap_biopharmaBi53','ch_asap_biopharmaBs53')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB53,ch_asap_biopharmaBck5,32.083302,34.766701"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB54\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081119/20081119005891.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi54\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB54','ch_asap_biopharmaBi54','ch_asap_biopharmaBt54','ch_asap_biopharmaBs54')\" onmouseout=\"tmo1('ch_asap_biopharmaBt54','ch_asap_biopharmaBi54','ch_asap_biopharmaBs54')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB54,ch_asap_biopharmaBck5,35.825523,-78.316673"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB55\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081117/20081117005951.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi55\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB55','ch_asap_biopharmaBi55','ch_asap_biopharmaBt55','ch_asap_biopharmaBs55')\" onmouseout=\"tmo1('ch_asap_biopharmaBt55','ch_asap_biopharmaBi55','ch_asap_biopharmaBs55')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB55,ch_asap_biopharmaBck5,59.333302,18.083300"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB56\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/bw/081113/20081113005017.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_multicultural_32.bmp\" name=\"ch_asap_biopharmaBi56\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB56','ch_asap_biopharmaBi56','ch_asap_biopharmaBt56','ch_asap_biopharmaBs56')\" onmouseout=\"tmo1('ch_asap_biopharmaBt56','ch_asap_biopharmaBi56','ch_asap_biopharmaBs56')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB56,ch_asap_biopharmaBck5,42.279205,-85.583900"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB57\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081128/ukth023.html?.v=75\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_science_32.bmp\" name=\"ch_asap_biopharmaBi57\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB57','ch_asap_biopharmaBi57','ch_asap_biopharmaBt57','ch_asap_biopharmaBs57')\" onmouseout=\"tmo1('ch_asap_biopharmaBt57','ch_asap_biopharmaBi57','ch_asap_biopharmaBs57')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB57,ch_asap_biopharmaBck6,52.349998,4.900000"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB58\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081202/3795673en_public.html?.v=1\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_science_32.bmp\" name=\"ch_asap_biopharmaBi58\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB58','ch_asap_biopharmaBi58','ch_asap_biopharmaBt58','ch_asap_biopharmaBs58')\" onmouseout=\"tmo1('ch_asap_biopharmaBt58','ch_asap_biopharmaBi58','ch_asap_biopharmaBs58')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB58,ch_asap_biopharmaBck6,55.666530,12.583290"; ai=ai+1;
document.write("<div id=\"ch_asap_biopharmaB59\" style=\"position:absolute;left:0;top:0;\"><a href=\"http://biz.yahoo.com/prnews/081113/aqth057.html?.v=65\" TARGET=\"_blank\"><img src=\"/images/geo_news/icons/_science_32.bmp\" name=\"ch_asap_biopharmaBi59\" width=\"16\" height=\"16\"  onmouseover=\"tmo(event, 'ch_asap_biopharmaB59','ch_asap_biopharmaBi59','ch_asap_biopharmaBt59','ch_asap_biopharmaBs59')\" onmouseout=\"tmo1('ch_asap_biopharmaBt59','ch_asap_biopharmaBi59','ch_asap_biopharmaBs59')\"></a></div>"); ar[ai] = "ch_asap_biopharmaB59,ch_asap_biopharmaBck6,33.684067,-117.792580"; ai=ai+1;

document.write("<div id=\"ch_asap_biopharmaBt0\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Eli Lilly completes ImClone buyout</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;INDIANAPOLIS,   -  Drug developer Eli Lilly and Co. said Monday that it has completed its $6 billion acquisition of ImClone Systems Inc. -- the company's biggest buyout in the biotechnology industry.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt1\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Memory selling to partner Roche for $50 million</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;MONTVALE, NJ -  Memory Pharmaceuticals Corp. said Tuesday Swiss drug developer Roche will buy the biotech company for about $50 million, in a move to bulk up its development of potential Alzheimer's disease and schizophrenia treatments.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt2\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Medivir Receives Milestone Payment from Research Collaboration with Tibotec in the Field of Hepatitis C Polymerase</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  STOCKHOLM, Sweden----Regulatory News:</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt3\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Data from Eight Clinical Trials Facilitated by the Multiple Myeloma Research Consortium (MMRC) Presented at the ...</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NORWALK, Conn.----The Multiple Myeloma Research Consortium today announced that data from eight clinical trials in its portfolio as well as findings from the MMRC Multiple Myeloma Genomics Initiative were presented at the American Society of Hematology s 50th Annual Meeting and Exposition held Dec. 6-9, 2008, in San Francisco, Calif.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt4\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Key Challenges and Issues Facing the World Biodiesel Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Oil industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt5\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">LifeScience Alley Conference & Expo 2008 Exhibitor Profiles</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  MINNEAPOLIS----LifeScience Alley Conference & Expo 2008 takes place December 10, 2008 at the Minneapolis Convention Center in Minneapolis. Listed below are the LifeScience Alley Conference & Expo 2008 exhibitor profiles.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt6\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Examine the World Wound Care Products Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt7\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Multiple Myeloma Research Consortium (MMRC) Honors Dr. Andrzej Jakubowiak, University of Michigan with 2008 Center of ...</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NORWALK, Conn.----The Multiple Myeloma Research Consortium today announced that it has awarded the University of Michigan Cancer Center and Andrzej Jakubowiak, MD, PhD, the 2008 MMRC Center of the Year Award.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt8\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">High Growth Reported for the Membrane Technology for Liquid and Gas Separations</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Advanced materials industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt9\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Tyrian Strengthens Board With New Appointment</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  SYDNEY, Australia----Tyrian Diagnostics Limited announced today the appointment of new board member, Dr Merilyn Sleigh and the resignation of John Martin.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt10\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Compugen and Merck Serono to Collaborate on Novel Peptide for the Treatment of Inflammatory Diseases</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  TEL AVIV, Israel----Compugen Ltd. announced today that it has signed a collaboration agreement with Merck KGaA, acting for its pharmaceutical division Merck Serono, covering CGEN-855, a Compugen-discovered novel peptide targeting the FPRL1 G-protein coupled receptor .</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt11\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network , Bristol-Myers Squibb Company and ImClone Systems Incorporated have entered into a collaboration to conduct a multi-institutional, investigator-initiated study in bladder cancer using cetuximab .</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt12\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">TaconicArtemis Announces Publication in PNAS: Inducible Gene Silencing in Transgenic Rats via RNAi</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  COLOGNE, Germany----TaconicArtemis GmbH, a subsidiary of Taconic today announced the publication of a scientific breakthrough achieved in a collaboration with the Universities Goettingen and Wuerzburg .</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt13\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Learn about the World Regenerative Medicine Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt14\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">High Growth Forecasted for the World Specialty Enzymes Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt15\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Learn about the World Molecular Diagnostics Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt16\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Quintiles, SAS Announce Development of First-Ever Clinical Trials Statistical Programming Certification</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  RESEARCH TRIANGLE PARK & CARY, N.C.----Quintiles, the world s No. 1 pharmaceutical services company, and SAS are developing a unique program to produce certified specialists in the use of SAS programming to evaluate clinical trials results, the companies announced today.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt17\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Washington States Leading Life Sciences Organization Names New President</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  SEATTLE----Chris E. Rivera has been named President of the Washington Biotechnology & Biomedical Association, succeeding retiring President Jack Faris.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt18\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Disrupting the Recession</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  DENVER----While today's economic climate has the timid on the sidelines, Colorado's collaborative entrepreneurial community will rise to the challenge. Contrarian investors and intrepid entrepreneurs with the courage to make intelligent bets will build new fortunes.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt19\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">ADMETRx & Roche Collaborate on Multicriteria Decision-Making Application</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  KALAMAZOO, Mich.----ADMETRx, a Contract Research group committed to providing the best in vitro ADME discovery support possible, has initiated a collaboration with Roche to advance the development of ADMETRx proprietary multi-criteria decision-making models applied to drug discovery.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt20\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">HemoGenix(R), Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in All Human HALO(R) ...</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;COLORADO SPRINGS, Colo -  HemoGenix  and ORF Genetics announce the collaboration and implementation of biorisk-free, green-source growth factors and cytokines for use in all HALO  Assay Kits and HALO  Contract Research Services where the response of human blood-forming cells is detected.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt21\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;OMAHA, Neb -  Transgenomic today announced that the Clayton Foundation for Research of Houston, Texas through its technology transfer entity, the Research Development Foundation, has granted the Company an exclusive license to patents covering a method for mitochondrial DNA damage detection.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt22\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;NEW YORK,   -  Sangamo BioSciences, Inc. announced that the company will provide an update on milestones achieved in 2008 and preview objectives for 2009 during its annual Investor and Analyst Briefing to be held in New York City today.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt23\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">New Research Will Benefit Four Million Americans Suffering from Chronic Fatigue Syndrome</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;CHARLOTTE, NC -  The four million Americans who suffer from chronic fatigue syndrome have new reason for hope today with the announcement of an unprecedented research program to help identify biomarkers for the illness and improve diagnosis and treatment of CFS.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt24\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;GOTHENBURG, SWEDEN -  Cellectricon, a leading provider of screening solutions for drug discovery, today announced the signing of a collaborative agreement with The Automation Partnership in the UK, manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt25\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Expansion of Product Portfolio: Prionics Enters Strategic Partnership With Ingenasa</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;ZURICH,   -  Prionics, a world leader in farm animal diagnostics, has entered into a strategic partnership with the Spanish company Ingenasa to make their innovative farm animal diagnostic solutions available to global markets.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt26\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Northern Power Names New Chief Executive Officer</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;BARRE, Vt -  Northern Power Systems, Inc., a next-generation wind energy company, announced today that John P. Danner has been appointed President and Chief Executive Officer.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt27\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;OMAHA, Neb -  Transgenomic today announced that the Clayton Foundation for Research of Houston, Texas through its technology transfer entity, the Research Development Foundation, has granted the Company an exclusive license to patents covering a method for mitochondrial DNA damage detection.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt28\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">NovaRx Appoints Industry Veteran as President and COO</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;SAN DIEGO,   -  NovaRx Corporation announced today the appointment of Norrie J.W. Russell, Ph.D to the position of President and Chief Operating Officer.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt29\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Syngenta, Dow AgroSciences Jointly to Develop Dow Compounds for Use in Syngenta Seed Care</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;INDIANAPOLIS and BASEL, SWITZERLAND -  Syngenta and Dow AgroSciences today announced a research and development agreement to evaluate current and future Dow AgroSciences compounds for incorporation into Syngenta's market-leading seed treatment portfolio.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt30\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;NEW YORK,   -  Sangamo BioSciences, Inc. announced that the company will provide an update on milestones achieved in 2008 and preview objectives for 2009 during its annual Investor and Analyst Briefing to be held in New York City today.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt31\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;ST. LOUIS,   -  Sigma-Aldrich and SouthWest NanoTechnologies Inc. , a leading producer of single-wall carbon nanotubes, announced today that they have signed an agreement under which Sigma-Aldrich will distribute SWeNT's single-wall carbon nanotubes to the research and development community.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt32\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market.</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;GOTHENBURG, SWEDEN -  Cellectricon, a leading provider of screening solutions for drug discovery, today announced the signing of a collaborative agreement with The Automation Partnership in the UK, manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt33\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Expansion of Product Portfolio: Prionics Enters Strategic Partnership With Ingenasa</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;ZURICH,   -  Prionics, a world leader in farm animal diagnostics, has entered into a strategic partnership with the Spanish company Ingenasa to make their innovative farm animal diagnostic solutions available to global markets.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt34\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Tibotec and Emcure Collaborate on Access to Darunavir for India</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;COUNTY CORK, IRELAND -  Tibotec Pharmaceuticals today announced that it has signed a royalty-free, non-exclusive license agreement with Emcure Pharmaceuticals Limited of India to distribute the protease inhibitor darunavir in India.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt35\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;PALO ALTO, CA -  Intradigm Corporation, a leading developer of targeted, systemic RNA interference therapeutics, today announced the issuance of United States patent 7,459,547, entitled 'Methods and Compositions for Controlling Efficacy of RNA Silencing.'</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt36\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA ...</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;SAN DIEGO,   -  Vical Incorporated announced today the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA cancer vaccine.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt37\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;FRAZER, Pa -  Cephalon, Inc. and ImmuPharma PLC , a European pharmaceutical company, today announced that the companies have signed an Option Agreement providing Cephalon with an option to obtain an exclusive, worldwide license to the investigational medication Lupuzor for the treatment of Systemic Lupus Erythematosus.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt38\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;ANN ARBOR, Mich -  MichBio, the association for Michigan's biosciences industry, welcomed nearly 500 biosciences professionals and service providers to its fourth annual Expo on Tuesday and Wednesday of this week at the Rock Financial ShowPlace in Novi, MI.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt39\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;HAYWARD, CA -  Arete Therapeutics Inc., a privately-held biotechnology company developing first-in-class soluble epoxide hydrolase inhibitors, today announced that it has closed the final tranche of its Series A financing.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt40\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">What's the Big Secret? Take the GEN Microarray Challenge to Find Out and Win $1,500</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;NEW ROCHELLE, NY -  If you thought the Da Vinci Code was exciting, try the GEN Microarray Challenge . Genetic Engineering & Biotechnology News along with partner, Scintellix , and sponsor, Agilent , are proud to bring you the puzzle that's sure to make you think.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt41\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Seattle Genetics Announces Interim Safety Analysis Supports Continuation of Lintuzumab Phase IIb Clinical Trial</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  BOTHELL, Wash.----Seattle Genetics, Inc. announced today that an Independent Data Monitoring Committee has completed a pre-specified safety review of data from the ongoing phase IIb trial of lintuzumab in combination with low-dose cytarabine chemotherapy for older patients with acute myeloid leukemia .</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt42\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Examine the World Intranasal Drug Delivery Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt43\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">High Growth Reported for the World Pulmonary Drug Delivery Technologies Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt44\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Examine the World Wound Care Products Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt45\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">LifeScience Alley Conference & Expo 2008 Exhibitor Profiles</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  MINNEAPOLIS----LifeScience Alley Conference & Expo 2008 takes place December 10, 2008 at the Minneapolis Convention Center in Minneapolis. Listed below are the LifeScience Alley Conference & Expo 2008 exhibitor profiles.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt46\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Celgene Corporation and Acceleron Pharma to Present ACE-011 Data at the 50th Annual Meeting of the American Society of ...</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  CAMBRIDGE, Mass.----Celgene Corporation and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that results from preclinical and clinical studies of ACE-011 will be presented at the annual meetings of the American Society of Hematology and the San Antonio Breast Cancer Symposium over a ...</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt47\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Seattle Genetics Reports Objective Responses with Dacetuzumab in Phase II Non-Hodgkin Lymphoma Trial</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  SEATTLE----Seattle Genetics, Inc. today reported data from a phase II single-agent clinical trial of dacetuzumab demonstrating objective responses at well-tolerated doses in heavily pre-treated patients with diffuse large B-cell lymphoma , an aggressive type of non-Hodgkin lymphoma.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt48\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Seattle Genetics Reports Durable Objective Responses with SGN-35 in Lymphoma</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  SEATTLE----Seattle Genetics, Inc. today reported data from a phase I clinical trial of SGN-35, an antibody-drug conjugate , demonstrating multiple complete and partial responses at well-tolerated doses in patients with relapsed or refractory Hodgkin lymphoma and other CD30-positive hematologic malignancies.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt49\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Examine the World Biocompatible Materials Market</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  NEW YORK----Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt50\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Seattle Genetics to Present at Upcoming Investor Conferences</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  BOTHELL, Wash.----Seattle Genetics, Inc. announced today that management will participate in two upcoming investor conferences.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt51\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">LifeCycle Pharma Announces Interim Report For the 9 Months Ended September 30, 2008</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  H RSHOLM, Denmark----LifeCycle Pharma A/S reported a net loss of DKK 69.1 million for the first nine months of 2008, compared to a net loss of DKK 87.9 million for the same period in 2007.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt52\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Compugen and Merck Serono to Collaborate on Novel Peptide for the Treatment of Inflammatory Diseases</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  TEL AVIV, Israel----Compugen Ltd. announced today that it has signed a collaboration agreement with Merck KGaA, acting for its pharmaceutical division Merck Serono, covering CGEN-855, a Compugen-discovered novel peptide targeting the FPRL1 G-protein coupled receptor .</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt53\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Dr. Dov Rubin Appointed Chief Executive Officer of Itamar Medical</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  TEL AVIV, Israel----Itamar Medical has announced the appointment of Dr. Dov Rubin as its Chief Executive Officer. Dov will be following Israel Schreiber.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt54\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Quintiles, SAS Announce Development of First-Ever Clinical Trials Statistical Programming Certification</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  RESEARCH TRIANGLE PARK & CARY, N.C.----Quintiles, the world s No. 1 pharmaceutical services company, and SAS are developing a unique program to produce certified specialists in the use of SAS programming to evaluate clinical trials results, the companies announced today.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt55\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Meda: European Collaboration Agreement in Dermatology</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  STOCKHOLM, Sweden----Regulatory News:</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt56\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">ADMETRx & Roche Collaborate on Multicriteria Decision-Making Application</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp; -  KALAMAZOO, Mich.----ADMETRx, a Contract Research group committed to providing the best in vitro ADME discovery support possible, has initiated a collaboration with Roche to advance the development of ADMETRx proprietary multi-criteria decision-making models applied to drug discovery.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt57\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;AMSTERDAM,   -  Oncology focused biopharmaceutical company Kiadis Pharma announces today that Andrea Velardi, M.D., Professor of Clinical Immunology at the University of Perugia, Italy and Kiadis Pharma are continuing their collaboration on ATIR, a product in clinical development for enabling the use of a mismatched donor in a bone marrow transplantation by preventing acute Graft versus Host Disease for end ...</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt58\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">Biomonitor Acquires the Irish Theranostic Company Neutekbio</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;COPENHAGEN,   -  Biomonitor A/S has completed the acquisition of the Irish company Neutekbio Ltd. on 27 November 2008. Neutekbio's technologies and products complement perfectly Biomonitor's current offerings to physicians and clinics involved in treatment of patients with Multiple Sclerosis, Rheumatoid Arthritis and Crohn's disease worldwide.</span></div>")
document.write("<div id=\"ch_asap_biopharmaBt59\" style=\"position:absolute;left:154;top:-100000;\"><font size=4 color =#33ff00><SPAN STYLE=\"background: #004400\">IDM Pharma Reports Third Quarter Financial Results</span><b><font size=3 color =#ffffff><SPAN STYLE=\"background: #444444\">&nbsp;&nbsp;&nbsp;IRVINE, CA -  IDM Pharma, Inc. today reported financial results for the quarter ended September 30, 2008.</span></div>")

newY=vertoff1+22+255; svv=1;


document.write("<div style=\"position:absolute;left:0;top:0;\"><img src=\"space.gif\"  width=\"1010\" height=\"22\" > </div>");
document.write("<font size=2 color =#33ff00>")
document.write("<FORM name=\"cbox2\">");
document.write("<div id=\"b20\" style=\"position:absolute;left:3;top:0;\"><INPUT TYPE=CHECKBOX  NAME=\"b20\"  ONCLICK=\"more()\">&gt;</div>");
document.write("<div id=\"b21\" style=\"position:absolute;left:43;top:0;\"><INPUT TYPE=CHECKBOX  NAME=\"b21\"  ONCLICK=\"less()\">&lt;</div>");
document.write("<div id=\"b22\" style=\"position:absolute;left:83;top:0;\"><INPUT TYPE=CHECKBOX  NAME=\"b22\"  ONCLICK=\"moremax()\">Max</div>");
document.write("<div id=\"b2\" style=\"position:absolute;left:180;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(0)\"   >World</div>");
document.write("<div id=\"b3\" style=\"position:absolute;left:260;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(1)\" >USA</div>");
document.write("<div id=\"b4\" style=\"position:absolute;left:330;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(2)\" >Europe</div>");
document.write("<div id=\"b5\" style=\"position:absolute;left:410;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(3)\" >Asia</div>");
document.write("<div id=\"b6\" style=\"position:absolute;left:485;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(4)\" >Indonesia</div>");
document.write("<div id=\"b7\" style=\"position:absolute;left:590;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(5)\" >Australia</div>");
document.write("<div id=\"b8\" style=\"position:absolute;left:690;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(6)\" >S America</div>");
document.write("<div id=\"b9\" style=\"position:absolute;left:800;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"  ONCLICK=\"pview(7)\" >Africa</div>");
document.write("<div id=\"b10\" style=\"position:absolute;left:870;top:0;\"><INPUT TYPE=RADIO  NAME=\"b2\"   ONCLICK=\"pview(8)\">Mid East</div>");

document.write("</FORM> </div>");
tot=ai ;

prespacer();
allo=1;
pview(svv);
if(newY>(vertoff1+72)) newY=(vertoff1+72);
if(newY<(vertoff1+22)) newY=(vertoff1+22);
kv=2+newY-22;
ca();